- Home
- QRVO vs ELAN Comparison
QRVO vs ELAN Comparison
Compare QRVO & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QRVO
- ELAN
- Stock Information
- Founded
- QRVO 1957
- ELAN 1954
- Country
- QRVO United States
- ELAN United States
- Employees
- QRVO N/A
- ELAN N/A
- Industry
- QRVO Semiconductors
- ELAN Biotechnology: Pharmaceutical Preparations
- Sector
- QRVO Technology
- ELAN Health Care
- Exchange
- QRVO Nasdaq
- ELAN Nasdaq
- Market Cap
- QRVO 6.6B
- ELAN 5.4B
- IPO Year
- QRVO 1997
- ELAN 2018
- Fundamental
- Price
- QRVO $71.06
- ELAN $10.04
- Analyst Decision
- QRVO Hold
- ELAN Buy
- Analyst Count
- QRVO 19
- ELAN 6
- Target Price
- QRVO $91.65
- ELAN $15.00
- AVG Volume (30 Days)
- QRVO 2.2M
- ELAN 4.8M
- Earning Date
- QRVO 04-30-2025
- ELAN 02-25-2025
- Dividend Yield
- QRVO N/A
- ELAN N/A
- EPS Growth
- QRVO N/A
- ELAN N/A
- EPS
- QRVO 0.28
- ELAN 0.68
- Revenue
- QRVO $3,790,485,000.00
- ELAN $4,439,000,000.00
- Revenue This Year
- QRVO $0.12
- ELAN $3.20
- Revenue Next Year
- QRVO N/A
- ELAN $4.26
- P/E Ratio
- QRVO $252.77
- ELAN $14.86
- Revenue Growth
- QRVO 9.51
- ELAN 0.50
- 52 Week Low
- QRVO $64.54
- ELAN $10.17
- 52 Week High
- QRVO $130.99
- ELAN $18.80
- Technical
- Relative Strength Index (RSI)
- QRVO 41.70
- ELAN 32.42
- Support Level
- QRVO $68.14
- ELAN $10.66
- Resistance Level
- QRVO $76.98
- ELAN $11.19
- Average True Range (ATR)
- QRVO 3.16
- ELAN 0.46
- MACD
- QRVO -0.08
- ELAN -0.04
- Stochastic Oscillator
- QRVO 24.78
- ELAN 0.34
About QRVO Qorvo Inc.
Qorvo represents the combined entity of RF Micro Devices and TriQuint Semiconductor, which merged in January 2015. The company specializes in radio frequency filters, power amplifiers, and front-end modules used in many of the world's most advanced smartphones. Qorvo also has a suite of products sold into a variety of nonsmartphone end markets, such as wireless base stations, cable TV and networking equipment, and infrastructure and military applications.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.